5 pharmaceutical products, namely, anti-inflammatories, biologicals for use in the treatment of schizophrenia, psychotic agitated states, acute allergic reactions, rheumatoid arthritis, non-life threatening drug reactions, bronchial treatment, rheumatic disorders, systemic lupus, contact dermatitis, certain leukemias and lymphomas, lower respiratory infections, urinary tract infections and skin and soft tissue infection due to susceptible strains of streptococci, staphylococci, and pneumococci, painful or hypertrophic scars, painful joints of rheumatoid arthritis, and acute or chronic idiopathic thrombocytic purpura